GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
8FXC | 8FXC | SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
8FXB | Q9BYF1 | SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
8FXB | P0DTC2 | SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
8FXB | 8FXB | SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
8FWW | P42260 | Structure of the ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 and noncompetitive inhibitor perampanel | |
8FWV | P42260 | Structure of the amino-terminal domain of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 and noncompetitive inhibitor perampanel | |
8FWU | P42260 | Structure of the ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 and competitive antagonist DNQX | |
8FWT | P42260 | Structure of the amino terminal domain of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 and competitive antagonist DNQX | |
8FWS | P42260 | Structure of the ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 | |
8FWR | P42260 | Structure of the amino-terminal domain of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 | |
8FWQ | P42260 | Structure of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 | |
8FUX | A0A0H2Z2W8 | KpsC D160C ternary complex | |
8FUW | A0A0H2Z2W8 | KpsC D160N Kdo adduct | |
8FU9 | P0DTC2 | Structure of Covid Spike variant deltaN25 with one erect RBD | |
8FU8 | P0DTC2 | Structure of Covid Spike variant deltaN135 with one erect RBD | |
8FU7 | P0DTC2 | Structure of Covid Spike variant deltaN135 in fully closed form | |
8FT4 | O67854 | Multicrystal structure of Na+, leucine-bound LeuT determined at 5 keV | |
8FSZ | E9QLC0 | Full-length mouse 5-HT3A receptor in complex with ALB148471, open-like | |
8FSP | E9QLC0 | Full-length mouse 5-HT3A receptor in complex with SMP100, open-like | |
8FSJ | 8FSJ | Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520 | |
8FSJ | A0A2P0NE34 | Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520 | |
8FSJ | 8FSJ | Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520 | |
8FSJ | A0A2P0NE34 | Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520 | |
8FSJ | A0A2P0NE15 | Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520 | |
8FSJ | A0A2P0NE15 | Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520 | |
8FSB | E9QLC0 | Full-length mouse 5-HT3A receptor in complex with serotonin, open-like | |
8FRZ | E9QLC0 | Full-length mouse 5-HT3A receptor in complex with serotonin, pre-activated | |
8FRX | E9QLC0 | Full-length mouse 5-HT3A receptor in complex with SMP100, pre-activated | |
8FRW | E9QLC0 | Full-length mouse 5-HT3A receptor in complex with ALB148471, pre-activated | |
8FRN | Q6FC66 | Acinetobacter baylyi LptB2FG bound to lipopolysaccharide and Zosurabalpin | |
8FRN | Q6FFD7 | Acinetobacter baylyi LptB2FG bound to lipopolysaccharide and Zosurabalpin | |
8FRN | Q6FFD6 | Acinetobacter baylyi LptB2FG bound to lipopolysaccharide and Zosurabalpin | |
8FRL | Q6FC66 | Acinetobacter baylyi LptB2FG bound to lipopolysaccharide and a macrocyclic peptide | |
8FRL | Q6FFD7 | Acinetobacter baylyi LptB2FG bound to lipopolysaccharide and a macrocyclic peptide | |
8FRL | Q6FFD6 | Acinetobacter baylyi LptB2FG bound to lipopolysaccharide and a macrocyclic peptide | |
8FRG | Q91XA9 | Mouse acidic mammalian chitinase, catalytic domain in complex with N,N'-diacetylchitobiose at pH 5.43 | |
8FRD | Q91XA9 | Mouse acidic mammalian chitinase, catalytic domain in complex with N,N'-diacetylchitobiose at pH 5.25 | |
8FRC | Q91XA9 | Mouse acidic mammalian chitinase, catalytic domain in complex with N,N'-diacetylchitobiose at pH 4.91 | |
8FRB | Q91XA9 | Mouse acidic mammalian chitinase, catalytic domain in complex with N,N'-diacetylchitobiose at pH 5.25 | |
8FRA | Q91XA9 | Mouse acidic mammalian chitinase, catalytic domain in complex with diacetylchitobiose at pH 5.60 | |
8FR9 | Q91XA9 | Mouse acidic mammalian chitinase, catalytic domain in complex with N,N'-diacetylchitobiose at pH 5.08 | |
8FR7 | Q6Q1S2 | A hinge glycan regulates spike bending and impacts coronavirus infectivity | |
8FR6 | Q2N0S7 | Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
8FR6 | Q2N0S6 | Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
8FR6 | 8FR6 | Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
8FQ9 | P30878 | Crystal structure of a ligand-bound cation-site mutant D55C of a melibiose transporter | |
8FOI | P62812 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
8FOI | P63137 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
8FOI | P22723 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
8FOI | 8FOI | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024